These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 11861038)

  • 21. Circulating versus local renin-angiotensin system in cardiovascular homeostasis.
    Dzau VJ
    Circulation; 1988 Jun; 77(6 Pt 2):I4-13. PubMed ID: 3286045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue renin-angiotensin system in myocardial hypertrophy and failure.
    Dzau VJ
    Arch Intern Med; 1993 Apr; 153(8):937-42. PubMed ID: 8386920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen protects transgenic hypertensive rats by shifting the vasoconstrictor-vasodilator balance of RAS.
    Brosnihan KB; Li P; Ganten D; Ferrario CM
    Am J Physiol; 1997 Dec; 273(6):R1908-15. PubMed ID: 9435644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in the renin-angiotensin-aldosterone system in elderly patients with chronic ischemic heart disease. 4. The renin-angiotensin-aldosterone system in elderly patients with ischemic heart disease and cardiovascular insufficiency].
    Korkusko OV; Kalinovskaja EG; Fedirko MI; Gidzinskaja IN
    Z Alternsforsch; 1989; 44(3):149-54. PubMed ID: 2669367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RAA system and cardiovascular control in normal subjects, hypertensives and patients with congestive heart failure.
    Seravalle G; Cattaneo BM; Giannattasio C; Perondi R; Saino A; Grassi G; Mancia G
    J Hum Hypertens; 1993 Aug; 7 Suppl 2():S13-8. PubMed ID: 8230084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex differences in the metabolic effects of the renin-angiotensin system.
    White MC; Fleeman R; Arnold AC
    Biol Sex Differ; 2019 Jul; 10(1):31. PubMed ID: 31262355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The renin-angiotensin system as a target for therapeutic intervention.
    Swales JD
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S1-5. PubMed ID: 7898088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex differences in angiotensin II- and aldosterone-induced hypertension: the central protective effects of estrogen.
    Xue B; Johnson AK; Hay M
    Am J Physiol Regul Integr Comp Physiol; 2013 Sep; 305(5):R459-63. PubMed ID: 23883676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
    Abassi Z; Armaly Z; Nakhoul F; Hoffman A
    Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat.
    Schunkert H; Tang SS; Litwin SE; Diamant D; Riegger G; Dzau VJ; Ingelfinger JR
    Cardiovasc Res; 1993 May; 27(5):731-5. PubMed ID: 8348571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new look at the renin-angiotensin system--focusing on the vascular system.
    Nguyen Dinh Cat A; Touyz RM
    Peptides; 2011 Oct; 32(10):2141-50. PubMed ID: 21945916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of suppression of the circulating and vascular renin-angiotensin system by enalapril versus trandolapril in chronic heart failure.
    Jorde UP; Vittorio TJ; Dimayuga CA; Homma S; Rizkala A; Le Jemtel TH; Katz SD
    Am J Cardiol; 2004 Dec; 94(12):1501-5. PubMed ID: 15589004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.
    Cody RJ
    Drugs; 1984 Aug; 28(2):144-69. PubMed ID: 6205842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue renin-angiotensin systems. Their role in cardiovascular disease.
    Lee MA; Böhm M; Paul M; Ganten D
    Circulation; 1993 May; 87(5 Suppl):IV7-13. PubMed ID: 8485836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of genes of the cardiac and renal renin-angiotensin systems in preterm piglets: is this system a suitable target for therapeutic intervention?
    Kim E; Eiby Y; Lumbers E; Boyce A; Gibson K; Lingwood B
    Ther Adv Cardiovasc Dis; 2015 Oct; 9(5):285-96. PubMed ID: 25817302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of tanshinone II(A) on expression of different components in renin-angiotensin system of left ventricles of hypertensive rats].
    Yu LZ; Shi CR
    Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1468-72. PubMed ID: 25039184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the renin-angiotensin system in heart failure and hypertrophy--studies in human hearts and transgenic rats.
    Paul M; Pinto YM; Schunkert H; Ganten D; Böhm M
    Eur Heart J; 1994 Dec; 15 Suppl D():63-7. PubMed ID: 7713116
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the circulating and tissue-based renin-angiotensin system in the development of heart failure: implications for therapy.
    MacFadyen RJ
    Cardiology; 1993; 83(1-2):38-48. PubMed ID: 8261485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function.
    Izzo JL
    Heart Dis; 2000; 2(5):380-3. PubMed ID: 11728286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender modulates activation of renin-angiotensin and endothelin systems in hypertension and heart failure.
    Radin MJ; Holycross BJ; Sharkey LC; Shiry L; McCune SA
    J Appl Physiol (1985); 2002 Mar; 92(3):935-40. PubMed ID: 11842023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.